Document Detail


Management of the third stage of labor: a survey of practice among Texas obstetricians.
MedLine Citation:
PMID:  7817327     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Available evidence shows that the benefits of routine oxytocic administration in the third stage of labor far outweigh the potential risks. In 1990, T.F. Baskett, MD, reviewed the routine use of oxytocic drugs by Canadian obstetricians in the management of the third stage of labor. With Dr Baskett's permission, we sent a similar questionnaire to 1500 obstetricians in Texas: 1000 practiced in urban areas and 500 practiced in rural areas of the state. Ninety-four percent of Texas obstetricians answering the survey used oxytocics routinely in managing the third stage of labor. However, only 14.9% administered the oxytocics before delivery of the placenta, in contrast to 92.1% who gave oxytocics after the delivery of the placenta. Oxytocin was the chosen oxytocic drug for routine third-stage management (95%) as well as for postpartum hemorrhage (73.3%). Of the physicians surveyed, 55.9% used 15-methyl prostaglandin F2a (Hemabate) to treat postpartum hemorrhage refractory to other drugs within the past year. Of the respondents, 14.3% had managed acute uterine inversion during the past year. Thus, Texas obstetricians use Oxytocin routinely in the management of the third stage of labor, but few are converted to active management.
Authors:
C A Phillips; R A Kinch
Related Documents :
10405517 - Hybrid casts: a comparison of different casting materials.
21130217 - The challenges and opportunities of technological approaches to fatigue management.
9360517 - Management of incidental pituitary microadenomas: a cost-effectiveness analysis.
19911537 - Consensual medicine and the therapeutic partnership: reducing the costs of defensive me...
11789687 - Spermicidal activity of seed oil of pongamia glabra.
2525277 - Medicine in the industrial battle: early workers' compensation.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Texas medicine     Volume:  90     ISSN:  0040-4470     ISO Abbreviation:  Tex Med     Publication Date:  1994 Dec 
Date Detail:
Created Date:  1995-02-09     Completed Date:  1995-02-09     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0051012     Medline TA:  Tex Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  44-7     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Tarrant County Hospital District, Fort Worth, Tex.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Attitude of Health Personnel*
Canada
Carboprost / therapeutic use
Family Practice
Female
Humans
Labor Stage, Third*
Obstetrics*
Oxytocics / administration & dosage
Oxytocin / administration & dosage,  therapeutic use
Placenta
Postpartum Hemorrhage / prevention & control
Pregnancy
Rural Health
Texas
Urban Health
Uterine Diseases / therapy
Chemical
Reg. No./Substance:
0/Oxytocics; 35700-23-3/Carboprost; 50-56-6/Oxytocin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Video technology and the personal computer in the therapy simulator
Next Document:  Prevalence of HIV seropositivity among inner-city adolescents in 1988 and 1992.